5 Blood Markers Commonly Overlooked for Gut Health

ByRohan Smith
Decoding Your Blood Work: 5 Commonly Overlooked Indicators of Gut Health Issues

Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA

Quick Answer

Five commonly overlooked blood markers — C-reactive protein (CRP), serum zinc, vitamin B12, iron panel patterns, and liver enzymes (ALT and AST) — may reveal early signs of gut dysfunction even when digestive symptoms are absent. Interpreted together through a functional medicine lens, these markers can indicate intestinal permeability, malabsorption, dysbiosis, or gut–liver axis disruption before overt gastrointestinal disease develops.

At a Glance

  • Persistently elevated CRP may reflect low-grade gastrointestinal inflammation or increased intestinal permeability, as described in research by Bischoff et al. (2014).
  • Low serum zinc is associated with impaired intestinal epithelial barrier function and altered immune responses, according to Gammoh and Rink (2017).
  • Vitamin B12 deficiency can result from malabsorption rather than inadequate dietary intake, particularly when stomach acid or intrinsic factor production is compromised.
  • Iron panel abnormalities may occur even within standard reference ranges when small intestinal bacterial overgrowth (SIBO) or chronic gut inflammation is present.
  • Mildly elevated ALT and AST may indicate gut–liver axis disruption, where microbial endotoxins increase hepatic workload, as outlined by Tripathi et al. (2018).
  • Pattern recognition across multiple blood markers is more clinically informative than interpreting single results in isolation.

Beyond Basic Blood Tests: Why Gut Health Matters

The gastrointestinal tract is responsible for digestion, immune regulation, nutrient absorption, and metabolic signalling — functions that influence nearly every organ system. Disruption to gut function has been associated with symptoms such as bloating, fatigue, nutrient deficiencies, immune dysregulation, and changes in mood or energy levels. The World Gastroenterology Organisation recognises the gut microbiome as a key modulator of systemic health. Many of these patterns overlap with conditions commonly explored in functional medicine approaches to gut microbiome health.

How Blood Markers Reflect Gut Function

Gut dysfunction may influence systemic inflammation, micronutrient status, and hepatic workload through well-characterised pathways including the gut–liver axis, immune-mediated intestinal permeability, and microbial metabolite signalling. Although blood markers do not diagnose gut conditions in isolation, recurring patterns across multiple results — as described in functional medicine literature — may suggest impaired digestion, intestinal barrier disruption, or altered gut microbiota activity. The table below summarises the five key markers and their potential gut health implications.

Blood Marker Normal Function Potential Gut-Related Significance
C-Reactive Protein (CRP) Acute-phase inflammatory marker produced by the liver May reflect chronic gut inflammation or increased intestinal permeability
Serum Zinc Immune regulation, enzyme activity, epithelial integrity Low levels associated with impaired gut barrier function
Vitamin B12 Neurological function, red blood cell production Deficiency may indicate malabsorption in the stomach or small intestine
Iron Panel (ferritin, serum iron, transferrin) Oxygen transport, energy metabolism Abnormal patterns may reflect SIBO, gut inflammation, or impaired absorption
Liver Enzymes (ALT, AST) Hepatic function and cellular integrity Mild elevations may indicate gut–liver axis disruption and endotoxin exposure

Marker #1: Elevated C-Reactive Protein (CRP)

C-reactive protein is a hepatic acute-phase reactant that rises in response to interleukin-6 (IL-6) signalling during systemic inflammation. Persistently elevated CRP levels may be associated with chronic inflammatory states, including those linked to gastrointestinal inflammation or increased intestinal permeability. Research by Bischoff et al., published in BMC Gastroenterology (2014), identified intestinal barrier dysfunction as a contributing factor in systemic low-grade inflammation. Low-grade inflammation originating in the gut may contribute to elevated CRP, particularly in individuals with food sensitivities, dysbiosis, or inflammatory bowel conditions such as Crohn’s disease or ulcerative colitis. High-sensitivity CRP (hs-CRP) testing may offer greater precision in detecting subclinical inflammatory patterns.

Marker #2: Low Serum Zinc

Zinc is an essential trace mineral involved in over 300 enzymatic reactions, including immune regulation, antioxidant defence, and the maintenance of intestinal epithelial tight junction integrity. Gammoh and Rink, writing in Nutrients (2017), detailed zinc’s role in modulating both innate and adaptive immune responses.

Low serum zinc levels may be associated with impaired gut barrier function and altered immune responses. Research by Sauer et al. in Annals of Nutrition and Metabolism (2016) linked suboptimal zinc status to increased intestinal permeability, sometimes described clinically as intestinal barrier dysfunction. Zinc-dependent metalloproteinases and tight junction proteins such as claudin and occludin may be compromised when zinc status is inadequate.

Marker #3: Vitamin B12 Deficiency and Malabsorption

Vitamin B12 (cobalamin) is required for methylation reactions, neurological function, red blood cell production, and mitochondrial energy metabolism. O’Leary and Samman, publishing in Nutrients (2010), described the complex multi-step absorption process that makes B12 particularly vulnerable to gastrointestinal disruption. Low or borderline B12 levels may reflect impaired absorption rather than inadequate dietary intake, particularly in conditions affecting the stomach or small intestine. Reduced stomach acid (hypochlorhydria), intrinsic factor impairment related to parietal cell dysfunction, or small intestinal inflammation may interfere with effective B12 absorption. Allen (2008), in the Food and Nutrition Bulletin, noted that malabsorptive causes of B12 deficiency are frequently underrecognised in clinical practice.

Marker #4: Iron Patterns — When “Normal” Isn’t Optimal

Iron homeostasis is tightly regulated by the hormone hepcidin and is closely linked to gut health, as described by Ganz and Nemeth in Nature Reviews Immunology (2015). Some individuals experience fatigue or weakness despite ferritin or serum iron values that fall within standard reference ranges. Weiss and Goodnough, writing in the New England Journal of Medicine (2005), described how chronic inflammation can alter iron distribution without causing frank deficiency — a pattern termed anaemia of chronic disease. Altered gut microbiota, small intestinal bacterial overgrowth (SIBO), or chronic gut inflammation may affect iron absorption, utilisation, or storage without meeting criteria for overt iron deficiency. These patterns are frequently explored in people seeking support for chronic fatigue.

Marker #5: Elevated Liver Enzymes and the Gut–Liver Axis

Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are intracellular enzymes commonly used to assess hepatocellular stress or injury. Tripathi et al., publishing in Hepatology (2018), characterised the gut–liver axis as a bidirectional communication pathway between intestinal microbiota and hepatic immune function. Mild elevations may sometimes reflect increased metabolic or inflammatory burden originating from the gut via this axis. Albillos et al., in the Journal of Hepatology (2020), described how impaired gut barrier function and microbial lipopolysaccharide (LPS) endotoxin exposure may increase hepatic workload, potentially contributing to liver enzyme elevation in some individuals. Cani et al. (2007) demonstrated in Diabetes that metabolic endotoxaemia driven by gut-derived LPS can initiate systemic inflammatory and metabolic cascades.

When to Consider Deeper Gut Investigation

Clinical Indicator Possible Gut-Related Connection
Persistent fatigue or brain fog despite unremarkable routine blood tests May suggest subclinical malabsorption or gut-mediated inflammation
Recurrent bloating, food reactions, or digestive discomfort May indicate dysbiosis, SIBO, or food sensitivity patterns
Multiple micronutrient deficiencies without a clear dietary explanation May reflect impaired intestinal absorption or gut barrier dysfunction
Elevated inflammatory markers with no obvious source May suggest gut-origin systemic inflammation or intestinal permeability

Next Steps: A Functional Medicine Perspective

  1. Review your blood work with a functional lens: Look beyond “normal” ranges. Patterns across CRP, zinc, B12, iron, and liver enzymes may collectively point to gut involvement even when individual results seem unremarkable.
  2. Consider targeted gut investigation: When blood markers suggest possible gut involvement, further assessment may include comprehensive stool analysis, lactulose breath testing for SIBO, dietary evaluation, or targeted nutritional strategies.
  3. Seek a systems-based approach: Functional medicine emphasises pattern recognition rather than isolated results. An overview of this approach is available through functional medicine services at Elemental Health and Nutrition.

Frequently Asked Questions

Can routine blood tests really show signs of gut health problems?
Yes. While blood tests cannot diagnose gut conditions on their own, certain markers may indirectly reflect gut dysfunction. Patterns involving inflammation markers such as CRP, nutrient levels including zinc and B12, and liver enzymes like ALT and AST can suggest issues such as impaired absorption, gut inflammation, or disruption of the gut–liver axis when interpreted together and in clinical context.

Why might nutrient deficiencies show up even with a healthy diet?
Nutrient deficiencies are not always caused by poor intake. Conditions affecting digestion, stomach acid production (hypochlorhydria), intestinal absorption, or gut microbiota balance can interfere with how nutrients such as zinc, vitamin B12, and iron are absorbed and utilised, even when dietary intake appears adequate. This is why functional medicine practitioners often assess gut function alongside nutrient status.

When should gut health be investigated further after blood test results?
Further investigation may be appropriate when multiple blood markers show recurring patterns, symptoms persist despite “normal” results, or unexplained fatigue, digestive discomfort, or micronutrient imbalances are present. A broader assessment — potentially including stool testing, breath testing, or dietary evaluation — can help clarify whether gut-related factors are contributing.

Key Insights

  • Routine blood markers including CRP, zinc, B12, iron panels, and liver enzymes may provide indirect insight into gut health
  • Patterns across multiple markers are more clinically informative than single results interpreted in isolation
  • Gut dysfunction can influence systemic inflammation, micronutrient status, and hepatic function via the gut–liver axis
  • Early identification of gut-related blood marker patterns may help reduce symptom progression and guide targeted investigation

Citable Takeaways

  1. Bischoff et al. (2014) identified intestinal barrier dysfunction as a potential contributor to systemic low-grade inflammation detectable via elevated CRP levels.
  2. Gammoh and Rink (2017) demonstrated that zinc deficiency may impair both innate and adaptive immune responses, with implications for intestinal epithelial integrity.
  3. Allen (2008) noted that malabsorptive causes of vitamin B12 deficiency are frequently underrecognised, and gastrointestinal conditions affecting the stomach or ileum may be primary contributors.
  4. Ganz and Nemeth (2015) described iron homeostasis as tightly regulated by hepcidin, and Weiss and Goodnough (2005) characterised how chronic inflammation can alter iron distribution without causing frank deficiency.
  5. Tripathi et al. (2018) characterised the gut–liver axis as a bidirectional communication pathway, and Cani et al. (2007) demonstrated that gut-derived lipopolysaccharide endotoxin can initiate metabolic endotoxaemia and systemic inflammation.

Looking Beyond “Normal” Results

If you’re experiencing ongoing fatigue, digestive symptoms, or recurring nutrient imbalances despite routine blood tests appearing normal, a deeper, systems-based assessment may be helpful. At Elemental Health and Nutrition, individuals in Adelaide are supported through personalised assessment and evidence-informed care aimed at uncovering contributing factors rather than treating results in isolation.

Book an Appointment

References

  1. Ford AC et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Gut. 2014;63(Suppl 1):i1-i57. https://doi.org/10.1136/gutjnl-2013-306609
  2. Bischoff SC et al. Intestinal permeability – a new target for disease prevention and therapy. BMC Gastroenterol. 2014 Nov 18;14:189. https://doi.org/10.1186/s12876-014-0189-7
  3. Calder PC et al. Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients. 2020 Apr 23;12(4):1181. https://doi.org/10.3390/nu12041181
  4. Gammoh NZ, Rink L. Zinc in infection and inflammation. Nutrients. 2017 Jun 17;9(6):624. https://doi.org/10.3390/nu9060624
  5. Sauer AK et al. Zinc deficiency. Ann Nutr Metab. 2016;68(Suppl 1):1-7. https://doi.org/10.1159/000445954
  6. O’Leary F, Samman S. Vitamin B12 in health and disease. Nutrients. 2010 Mar;2(3):299-316. https://doi.org/10.3390/nu2030299
  7. Allen LH. Causes of vitamin B12 and folate deficiency. Food Nutr Bull. 2008 Jun;29(2 Suppl):S20-34. https://doi.org/10.1177/15648265080292S105
  8. Zimmermann MB. Iodine deficiency. Endocr Rev. 2009 Jun;30(4):376-408. https://doi.org/10.1210/er.2009-0011
  9. Ganz T, Nemeth E. Iron homeostasis in host and microbe. Nat Rev Immunol. 2015 Jun;15(6):369-81. https://doi.org/10.1038/nri3818
  10. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005 Mar 10;352(10):1011-23. https://doi.org/10.1056/NEJMra041809
  11. Quigley EMM. Microbiota and functional gastrointestinal disorders: a review. Gastroenterol Clin North Am. 2019 Mar;48(1):1-15. https://doi.org/10.1016/j.gtc.2018.09.010
  12. Tripathi A et al. The gut-liver axis and the intersection with the microbiome. Hepatology. 2018 Aug;68(2):833-846. https://doi.org/10.1002/hep.29810
  13. Albillos A et al. The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 2020 Mar;72(3):558-577. https://doi.org/10.1016/j.jhep.2019.10.003
  14. Cani PD et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007 Jul;56(7):1761-72. https://doi.org/10.2337/db06-1491
  15. Tilg H, Moschen AR. Microbiota and diabetes: an evolving relationship. Nat Rev Immunol. 2014 Oct;14(10):692-702. https://doi.org/10.1038/nri3741

Ready to find answers?

Stop surviving. Start recovering.

Similar Posts